Quadrature Capital Ltd Makes New $70,000 Investment in BrainsWay Ltd. (NASDAQ:BWAY)

Quadrature Capital Ltd acquired a new position in shares of BrainsWay Ltd. (NASDAQ:BWAY) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 10,761 shares of the company’s stock, valued at approximately $70,000.

A number of other hedge funds also recently added to or reduced their stakes in BWAY. Acadian Asset Management LLC acquired a new stake in BrainsWay during the 3rd quarter worth approximately $28,000. Tucker Asset Management LLC lifted its position in BrainsWay by 1,686.9% during the 4th quarter. Tucker Asset Management LLC now owns 5,450 shares of the company’s stock worth $35,000 after acquiring an additional 5,145 shares during the period. Jump Financial LLC acquired a new stake in BrainsWay during the 4th quarter worth approximately $207,000. Legato Capital Management LLC acquired a new stake in BrainsWay during the 4th quarter worth approximately $542,000. Finally, Worth Venture Partners LLC lifted its holdings in shares of BrainsWay by 6.0% in the 3rd quarter. Worth Venture Partners LLC now owns 336,643 shares of the company’s stock valued at $1,360,000 after buying an additional 19,045 shares during the period. 30.11% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently commented on BWAY shares. Oppenheimer raised their price target on BrainsWay from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Thursday, May 9th. HC Wainwright reissued a “buy” rating and issued a $15.00 price target on shares of BrainsWay in a report on Wednesday, June 5th.

BrainsWay Stock Performance

Shares of BWAY stock opened at $6.07 on Friday. The stock has a fifty day moving average price of $5.81 and a 200 day moving average price of $6.00. The stock has a market cap of $101.19 million, a PE ratio of -67.44 and a beta of 1.23. BrainsWay Ltd. has a 1 year low of $2.01 and a 1 year high of $7.61.

BrainsWay (NASDAQ:BWAY) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.02. The firm had revenue of $9.10 million during the quarter, compared to analysts’ expectations of $8.65 million. BrainsWay had a negative return on equity of 3.98% and a negative net margin of 4.83%. As a group, equities research analysts predict that BrainsWay Ltd. will post 0.02 earnings per share for the current year.

BrainsWay Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.